tradingkey.logo
搜尋

Upexi Inc

UPXI
添加自選
0.994USD
-0.041-3.96%
收盤 09-10 16:00美東
66.43M總市值
虧損本益比TTM
盤後交易  (美東)0.000USD0.000

關於 Upexi Inc 公司

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc 簡介

公司代碼UPXI
公司名稱Upexi Inc
上市日期Jun 24, 2021
CEOMarshall (Allan)
員工數量59
證券類型Ordinary Share
年結日Jun 24
公司地址3030 Rocky Point Drive
城市TAMPA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33607
電話17013535425
網址https://upexi.com/
公司代碼UPXI
上市日期Jun 24, 2021
CEOMarshall (Allan)

Upexi Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
938.60K
+42.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
-33.33%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
-33.33%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.17M
+63.07%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
938.60K
+42.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
860.37K
+11.62%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
459.14K
+87.12%

常見問題

Upexi Inc的前五大股東是誰?

Upexi Inc的前五大股東如下: Allan Marshall ,

有多少機構持有Upexi Inc(UPXI)的股份?

截至2026Q1,共有122家機構持有Upexi Inc的股份,合計持有的股份價值約為23.05M,占公司總股份的34.45% 。與2025Q4相比,機構持股有所增加,增幅為-188428.00。

哪個業務部門對Upexi Inc的收入貢獻最大?

在2026Q1,Contract manufactured業務部門對Upexi Inc的收入貢獻最大,創收744.32K,占總收入的70.84% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有